ClinicalTrials.gg
CompletedNCT07164248TEEN-BMDUpdated Sep 15, 2025

Evaluation of Bone Mineral Density Indications and Outcomes in Female Adolescents: Implications for Early Detection of Osteopenia/Osteoporosis and Gynecologic Practice

An observational study in Bone Density, Osteopenia and Amenorrhea, sponsored by Bagcilar Training and Research Hospital. Completed at 1 site in Turkey (Türkiye). Open to female participants aged 12 Years to 21 Years. Per ClinicalTrials.gov, last updated 2025-09-15.

Primary conditionOsteoporosisRegistry: Bone Diseases, MetabolicReclassifiedWhy we changed it
Registry
Bone Diseases, Metabolic — the first condition term the registry derived for this study.
ClinicalTrials.gg
Osteoporosis
Why
  1. The study's title name Osteoporosis, a narrower term within Bone Diseases, Metabolic.
Confidence
High: the new condition is named in the study's own title. Of 46 hand-checked studies reclassified this way, 72% were exactly right and 89% in the right disease family; the registry's first term was right for 4% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Bagcilar Training and Research Hospital · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-only
Time perspective
Retrospective
Enrollment
74
Ages
12 Years to 21 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 67 studies in Osteoporosis with a site in Turkey — 14 open to participants now, 17 under way, none of them phase 3. Osteoporosis · Turkey.

Enrollment
29th of 36
74 · median 107
Started
2025
with 10 others
Observational
36 of 67
10 open now
Registered
51st of 67
by date
Lead sponsor
2 of 67
Bagcilar Training and Research Hospital

Among the 67 studies in Osteoporosis with a site in Turkey, this one is the 29th largest by enrollment of the 36 observational ones that give a count, is one of 11 that started in 2025, is one of 36 observational ones, and was the 51st registered.

Osteoporosis

1,602 studies on the registry are indexed under Osteoporosis; 209 are open to participants now.

Browse Osteoporosis studies →

Open to participants now

14 of the 67 studies in Osteoporosis with a site in Turkey are open now. Recruiting first, the newest first:

9 more — sign in →

All 14 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 133 Osteoporosis studies recruiting now, 77 (58%) set no upper age limit and 20 (15%) stop at 75 or younger; 9 take children under 18; 36 take healthy volunteers.

This study: 12 Years to 21 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 67 studies in Osteoporosis with a site in Turkey, or all of them as a file.
02

Study summary

This retrospective study evaluates bone mineral density (BMD) measurements obtained by dual-energy X-ray absorptiometry (DEXA) in adolescent girls aged 12 to 21 years at a tertiary care center. The study focuses on patients referred from the adolescent gynecology clinic as well as from other medical specialties.

Key objectives are:

Comparing the BMD indications and results requested from the gynecology department with the indications and BMD results requested from other departments. Thus, the BMD scores of patients with hypogonadism can be compared with other groups at risk for bone health.

To assess BMD Z-scores across specific gynecologic diagnoses, including premature ovarian insufficiency, functional hypothalamic amenorrhea (FHA), and hypogonadotropic hypogonadism.

To analyze the relationship between gynecologic clinical features-such as age at menarche and duration of amenorrhea-and BMD Z-scores.

By combining clinical, hormonal, and densitometric data, this study aims to identify risk factors for low bone density in adolescents, support earlier recognition of osteopenia/osteoporosis, and provide guidance for appropriate interventions in adolescent gynecology practice.

Read the detailed description

Adolescence is a critical period for bone mass acquisition, and disturbances during this stage may predispose to osteopenia or osteoporosis in later life. Various clinical conditions encountered in gynecology, endocrinology, and other specialties may require evaluation of bone mineral density (BMD). However, data on referral indications and bone health outcomes in adolescents remain scarce.

This retrospective study focuses on female adolescents aged 12-21 years who underwent dual-energy X-ray absorptiometry (DEXA) scans at a tertiary care center. The cohort includes patients referred from the adolescent gynecology clinic as well as those referred from other medical departments.

The study objectives are:

To compare referral indications for BMD testing between gynecology and other specialties.

To evaluate differences in BMD Z-scores across specific gynecologic diagnoses, including premature ovarian insufficiency (POI), functional hypothalamic amenorrhea (FHA), and hypogonadotropic hypogonadism.

To examine the relationship between clinical features (such as age at menarche and duration of amenorrhea) and BMD outcomes within the gynecology group.

The analysis will provide insight into how referral patterns, gynecologic and endocrine conditions, and clinical characteristics influence bone health in adolescent girls. By highlighting risk factors for low BMD, the study aims to support earlier recognition and management of bone health problems in this population.

03

Conditions studied

  • Bone Density
  • Osteopenia
  • Amenorrhea
  • Primary Amenorrhea

Browse trials for

Keywords

  • Osteoporosis
  • Amenorrhea
  • DEXA
  • Adolescent
  • Bone Health
  • Osteopenia
04

In context

Osteoporosis Reclassified

1,602 studies on the registry are indexed under Osteoporosis; 209 are open to participants now.

This study's enrollment of 74 is below the median of 160 across 456 observational studies indexed under Osteoporosis.

Browse Osteoporosis studies →

Lead sponsor

Bagcilar Training and Research Hospital is the lead sponsor of 56 studies on the registry; 7 are open to participants now.

Compared within Osteoporosis, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Bone Diseases, Metabolic. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
12 Years to 21 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Female adolescents aged 12-21 years who underwent bone mineral density (BMD) measurement by dual-energy X-ray absorptiometry (DEXA) at a tertiary care hospital. The study includes patients referred from the adolescent gynecology clinic as well as those referred from other medical specialties (e.g., pediatrics, endocrinology).

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Female adolescents aged 12-21 years
  • Underwent bone mineral density (BMD) measurement with DEXA at the study center between 2020 and 2025
  • Available clinical and biochemical records, including referral indication

Exclusion criteria

Exclusion Criteria:

  • Incomplete or missing BMD scan data
  • Insufficient clinical information in medical records
  • Patients with underlying conditions unrelated to bone health that preclude accurate evaluation (e.g., major skeletal deformities interfering with DEXA interpretation)
06

Study design

Observational model
Case-only
Time perspective
Retrospective
Enrollment
74 participants (actual)
Patient registry
No

Groups and cohorts

  • Cohort 1 - Adolescent gynecology referrals

    Patients referred for DEXA scans due to gynecologic indications such as hypogonadism, amenorrhea, premature ovarian insufficiency \[POI\], functional hypothalamic amenorrhea \[FHA\], or hypogonadotropic hypogonadism

  • Cohort 2 - Referrals from other specialties

    Patients referred for DEXA scans by other departments, such as pediatrics, endocrinology, or additional medical specialties

07

What researchers measure

Primary outcomes

  1. Bone Mineral Density (BMD) Z-scores in Adolescent Girls

    Comparison of BMD Z-scores between adolescents (12-21 years) referred from the adolescent gynecology clinic and those referred from other specialties.

    Time frame: At the time of DEXA scan (retrospective chart review, 2020-2025

08

Study locations

1 site
  • Bagcilar Training and Research Hospital
    Istanbul, 34200, Turkey (Türkiye)
09

References and documents

Individual participant data

Plan to share: No — No individual participant data (IPD) will be shared. The study is retrospective and based on medical records, and patient confidentiality restrictions prevent data sharing.

No publications or documents are linked to this record.

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jun 2025 to primary completion in Jun 2025, 0 months.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 2, 2025
First posted
Sep 10, 2025
StartActual
Jun 1, 2025
Primary completionActual
Jun 15, 2025
CompletionActual
Aug 1, 2025
Last update
Sep 15, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 15, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT07164248
Lead sponsor
Bagcilar Training and Research Hospital
Responsible party
Nursen Kurtoglu Aksoy (Obstetrics and Gynecology Specialist, Bagcilar Training and Research Hospital, Bagcilar Training and Research Hospital) — Principal investigator
First posted
Sep 10, 2025
Start date
Jun 1, 2025
Primary completion
Jun 15, 2025
Completion
Aug 1, 2025
Last update
Sep 15, 2025

Study contacts

Nursen Kurtoglu
principal investigator · Bagcilar Training and Research Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion